Riskpilot← Back to searchSign inGet full accessAckerot Vårdkonsult AB
ABActiveOrg 5592724453Slingergatan 22Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2025
SEK 431K
+1% vs 2024
EBITDA margin
90.8%
-1% vs 2024
Equity ratio
90.7%
Financial strength
Net profit 2025
SEK 311K
-1% vs 2024
| Revenue | SEK 431K | +1% |
| EBITDA | SEK 391K | -1% |
| Net profit | SEK 311K | -1% |
| Total assets | SEK 576K | +15% |
| Equity | SEK 522K | +27% |
| Employees | 0 | — |
Legal name
Ackerot Vårdkonsult AB
Org number
5592724453
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarverksamhet främst inom psykiatri, föreläsningar, rådgivning och konsultationer samt därmed förenlig verksamhet. Bolaget ska även bedriva värdepappersförvaltning.
Address
Slingergatan 22
Email
hans.ackerot@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 340 | 370 | 490 | 426 | 431 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 301 | 333 | 449 | 394 | 391 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 301 | 333 | 449 | 394 | 391 |
| Net financials | — | 0 | 1 | 1 | −0 |
| Profit before tax | 301 | 333 | 450 | 395 | 391 |
| Tax | −65 | −69 | −93 | −81 | −81 |
| Net profit | 236 | 264 | 357 | 314 | 311 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 341 | 348 | 488 | 499 | 576 |
| Equity | 261 | 290 | 382 | 411 | 522 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 80 | 58 | 106 | 88 | 53 |
| Total debt | 80 | 58 | 106 | 88 | 53 |
EBITDA margin
90.8%
This company
15.8%
Market median
+475% vs market
20212025
Equity ratio
90.7%
This company
38.2%
Market median
+137% vs market
20212025
Return on equity
59.5%
This company
18.4%
Market median
+223% vs market
20212025
Net profit margin
72.1%
This company
8.1%
Market median
+790% vs market
20212025
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ackerot Vårdkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Markus Ingemar Gustafsson | Deputy Board Member | 0 companies |
| Lena Maria Patricia Ackerot | Deputy Board Member | 0 companies |
| Jonas Kenny Larsson | Board of Directors | 0 companies |
| Hans Olof Ackerot | Board of Directors | 0 companies |